Eli Lilly preparing €15 billion acquisition offer for French biotech Abivax, awaiting French Finance Ministry guidance Tirzepatide generated $24.8 billion revenue in first nine months of 2025, ...
Is NVO the next big buy?
Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback